225528-27-8Relevant academic research and scientific papers
VASOPRESSIN V1A ANTAGONISTS
-
Page/Page column 30, (2008/06/13)
The present invention concerns compounds inter alia according to general formula 1a. Compounds according to the invention are vasopressin V 1a receptor antagonists. Pharmaceutical compositions of the compounds are useful as treatment of dysmenorrhoea.
Piperazines as oxytocin agonists
-
Page/Page column 11-12, (2010/02/11)
Disclosed are novel compounds according to general formula I, which have shown OT agonist activity.
benzamide derivatives as oxytocin agonists and vasopressin antagonists
-
Page 25, (2010/02/08)
Novel compounds according to general formula 1, wherein G1 is NR5R6 or a fused polycyclic group that are specific OT receptor agonists and/or Via receptor antagonists. Pharmaceutical compositions comprising such compounds are useful in the treatment of, inter alia, primary dysmenorrhoea.
Para-aminomethylaryl carboxamide derivatives
-
, (2008/06/13)
para-Aminomethylaryl carboxamides of Formula I are antagonists of VLA-4 and/or α4β7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of asthma, allergies, inflammation, multiple sclerosis, and other inflammatory and autoimmune disorders.
